Products

Stuttgartmarketletter

Monthly Porsche market updates delivered to your inbox.

stuttgartmarketletter.com Creator Economy & Community / Newsletter & Blogging Platforms

AI Benchmark
Capture pending
Desktop
Mobile
Monthly visits
<5K
Sep 2026
MRR
$0
Down100.0%30d2026-07-30
Entry price
Unknown
No monthly subscription pricing
Creators
Whitlock
@davidkwhitlock· 284 followers
Launched
7y ago
2019-09-11 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on TrustMRRLaunch

    Daily Porsche Market Newsletter

    Sep 11, 2019 · 7y agoLaunch page

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Organic Search37%
  • Direct34%
  • Referrals9%
  • Social8%
  • Other12%

Countries

  • United States100%

Search

Domain authority 6Domain registered 2022-10-03

KeywordMonthly volume
gt3 mr1,330
gt4s730
porsche 997.1 for sale590
135k euros for a 997.2 gt3 cs350
997.2 years290

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-07-30

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Stuttgartmarketletter get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Stuttgartmarketletter and what platforms does it support?
Stuttgartmarketletter is catalogued under Newsletter & Blogging Platforms: Monthly Porsche market updates delivered to your inbox.. Supported platforms: Web.
What is Stuttgartmarketletter's publicly disclosed revenue?
TrustMRR records verified MRR of $0 observed on 2026-07-30.Source

Related products in this category

Creator Economy & Community / Newsletter & Blogging Platforms

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.